Cholest-5-en-3-yl beta-D-glucopyranosiduronic acid

(2S,3S,4S,5R,6R)-6-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

IJLBJBCDNYOWPJ-BBPBCBHPSA-N CHEBI:176746 0 Reactome links 1 studies

Metabolite details

Identifier: IJLBJBCDNYOWPJ-BBPBCBHPSA-N
InChI Key: IJLBJBCDNYOWPJ-BBPBCBHPSA-N
IUPAC name: (2S,3S,4S,5R,6R)-6-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Preferred name: Cholest-5-en-3-yl beta-D-glucopyranosiduronic acid
INN name: —
Synonym: —
ChEBI: CHEBI:176746

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head

Observed in differential profiles

Control_vs_AONFH_Stage_III_IV